HST Global Inc. Depreciation/Fixed assets

Depreciation/Fixed assets of HSTC for past 10 years: annual, quarterly and twelve month trailing (TTM) including Depreciation/Fixed assets growth rates and interactive chart.

Highlights and Quick Summary

  • Annual Depreciation/Fixed assets for 2011 was 0.0 (a -100.0% decrease from previous year)
  • Annual Depreciation/Fixed assets for 2010 was 2.0 (a 199.99% increase from previous year)
  • Twelve month Depreciation/Fixed assets ending December 30, 2011 was 0.0 (a NaN% decrease compared to previous quarter)
  • Twelve month trailing Depreciation/Fixed assets decreased by NaN% year-over-year
Trailing Depreciation/Fixed assets for the last four month:
30 Dec '11 29 Sep '11 29 Jun '11 30 Mar '11
0.0 0.0 0.0 0.0
Visit stockrow.com/HSTC for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Depreciation/Fixed assets of HST Global Inc.

Most recent Depreciation/Fixed assetsof HSTC including historical data for past 10 years.

Interactive Chart of Depreciation/Fixed assets of HST Global Inc.

HST Global Inc. Depreciation/Fixed assets for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2011 0.0
2010 2.0
2009 0.67

Business Profile of HST Global Inc.

Sector: Medical
Industry: Drugs
HST Global, Inc., an integrated health and wellness biotechnology company, develops and/or acquires a network of wellness centers for the homeopathic and alternative treatment of late stage cancer worldwide. It also focuses on the homeopathic and alternative product candidates that are undergoing or have already completed clinical testing for the treatment of late stage cancers and other life threatening diseases. The company also intends to acquire products for the treatment of individual health challenges. HST Global, Inc. is headquartered in Hampton, Virginia.